American Well Corporation

American Well Corp. engages in the provision of online healthcare services. It offers a single platform to support all telehealth needs from urgent to acute and post-acute care, chronic care management, and healthy living. Its services include urgent care, behavioral health, breastfeeding support, chronic care, nutrition counseling, pediatrics, telestroke, and virtual primary care. The company was founded by Ido Schoenberg and Roy Schoenberg in June 2006 and is headquartered in Boston, MA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

AMWL reports Q4 achievements, eyes revenue growth through Converge

AMWL's Q4 performance highlighted achievements in client migrations and strategic partnerships, with a focus on revenue growth for 2023.
Strengths include ACV growth, strong demand for behavioral health solutions, and the potential of the Converge platform to drive integration.
Challenges lie in revenue outlook impacted by customer churn, while opportunities exist in driving growth through Converge and service revenue.
Despite uncertainties, AMWL remains confident in its position in the digital care market and readiness to capitalize on market opportunities.

American Well (AMWL) reports Q1 growth amid margin challenges

AMWL's Q1 performance showed revenue growth but challenges in margins due to operational factors.
The company's focus on customer relationships and solution-based sales strategy are key strengths.
Opportunities lie in leveraging subscription revenue, market receptivity, and a strong financial position for future growth.
Challenges include margin pressures, limited growth avenues without mergers, and market scrutiny on key operational metrics.

American Well (AMWL) excels in Q2 with Converge migrations and international partnerships

AMWL's Q2 performance showcased strong client migrations, new wins, and international partnerships, with a focus on profitability.
Converge's modularity and end-to-end experience drive efficiency and positive renewals, while challenges include managing churn and pricing.
Opportunities in successful client migrations, market shift towards production platforms, and behavioral health integration are key growth areas.
Efforts to simplify the customer journey and accelerate ROI realization through modular approaches are underway for AMWL.

AMWL excels in Q3 with government wins and strategic partnerships

American Well Corporation's Q3 earnings call highlighted strong performance, strategic wins, and operational improvements positioning the company for future growth.
While facing challenges with legacy platforms, AMWL's focus on Converge, cost savings, and client engagement presents opportunities for enhanced profitability.
With a clear roadmap for growth and a focus on customer-centric solutions, AMWL is poised for significant revenue expansion and margin improvement in the coming years.

AMWL reports solid Q4 performance, eyes revenue growth opportunities

AMWL's Q4 performance reflects strategic advancements, high client satisfaction, and revenue diversification, positioning the company for future growth.
While facing challenges in achieving breakeven EBITDA and addressing subscription revenue declines, AMWL's strengths in market traction and sales model transformation offer growth opportunities.
Guidance for 2024 and 2025 outlines a clear path towards revenue growth, improved EBITDA, and leveraging Converge for enhanced customer value and revenue generation.

American Well (AMWL) reports strong Q1 growth and eyes retail expansion

American Well's Q1 performance showcased growth and cost structure improvements, with a focus on subscription revenue.
The company's strategic initiatives target efficiency improvements and higher-margin software subscriptions.
Opportunities lie in market shifts towards complete healthcare solutions and expansion with existing customers.
Challenges include cost initiatives towards profitability and addressing impacts of lower subscription software revenue.

American Well Corp. reports revenue growth and boosts EBITDA guidance

AMWL's Q2 2024 performance reflects positive revenue growth, improved gross profit margin, and adjusted EBITDA guidance raise, underlining the company's progress.
While facing challenges in achieving positive EBITDA and operational efficiency, AMWL's strengths in customer relationships, cost-cutting measures, and market positioning offer strategic advantages.
Opportunities for AMWL include optimizing spend, expanding client base, and leveraging its unique position in the digital healthcare market to drive future growth and profitability.

American Well Corp reports Q3 growth and strategic positioning

American Well Corporation (AMWL) demonstrated steady revenue growth and a commitment to strategic initiatives in Q3 2024.
While facing challenges in achieving profitability, the company's focus on cost alignment and growth positioning bodes well for future performance.
Opportunities in leveraging key contracts and subscription revenue growth position AMWL for continued success in the healthcare technology sector.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

American Well Corporation (NYSE:AMWL ) Q1 2024 Earnings Call Transcript May 1, 2024 5:00 PM ET Company Participants Sue Dooley - Head of Investor Relations Ido Schoenberg - Chairman & Chief Executive Officer Robert Shepardson - Chief Financial Officer Conference Call Participants Charles Rhyee - TD Cowen Craig Hettenbach - Morgan Stanley Jessica Tassan - Piper Sandler Jailendra Singh - Truist Securities Matthew Shea - Needham & Company Stan Berenshteyn - Wells Fargo Securities Hanna Lee - Bank of America Jenny Shen - BTIG Jack Wallace - Guggenheim Securities Operator Good afternoon. My name is Briana, and I will be your conference operator today.

American Well Corporation (AMWL) Q1 2024 Earnings Call Transcript

Although the revenue and EPS for American Well (AMWL) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Compared to Estimates, American Well (AMWL) Q1 Earnings: A Look at Key Metrics

American Well Corporation (AMWL) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.24 per share a year ago.

American Well Corporation (AMWL) Reports Q1 Loss, Misses Revenue Estimates

Boston, April 17, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in hybrid care enablement, will report its first quarter 2024 operating results Wednesday, May 1.

Amwell® to Report First Quarter 2024 Operating Results May 1

Boston, April 04, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of healthcare software as a service, today announced that it received a notice on April 2, 2024 from the New York Stock Exchange (NYSE) informing the company that it is not in compliance with the NYSE's continued listing minimum price criteria with respect to its Class A common stock because the average closing price of the company's Class A common stock was less than $1 per share over a consecutive 30 trading-day period. The notice does not result in the immediate delisting of the company's Class A common stock from the NYSE.

Amwell Receives Continued Listing Standard Notice From NYSE

Amwell clients to present on automated care, Converge platform integration Amwell clients to present on automated care, Converge platform integration

Power of Amwell Hybrid Care Solutions to be Highlighted at HIMSS 2024

Horner brings to the role 25 years in family medicine, completion of 25,000 virtual care visits Horner brings to the role 25 years in family medicine, completion of 25,000 virtual care visits

Amwell Names Cynthia Horner, M.D., Chief Medical Officer

Boston, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in hybrid care enablement, announced that company executives will participate in the TD Cowen Health Care Conference on Tuesday, March 5 in Boston.

Amwell to Participate in Upcoming Investor Conference

The headline numbers for American Well Corporation (AMWL) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

American Well Corporation (AMWL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Amwell announced better-than-expected fourth-quarter results. The telemedicine platform provider also issued strong preliminary 2025 guidance.

Why American Well Corporation Stock Soared Today

Company leaders to moderate or speak at sessions on virtual care delivery, GLP-1s Company leaders to moderate or speak at sessions on virtual care delivery, GLP-1s

Amwell Executives to Take the Stage at ViVE 2024

American Well Corporation (AMWL) Q4 2023 Earnings Call Transcript

American Well Corporation (AMWL) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to loss of $0.22 per share a year ago.

American Well Corporation (AMWL) Reports Q4 Loss, Tops Revenue Estimates

Boston, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL) a leader in hybrid care enablement, today announced financial results for the fourth quarter and full year ended Dec. 31, 2023. Amwell is a small-cap growth company and a leading provider of healthcare software as a service.

Amwell Announces Results for Fourth Quarter and Full Year 2023

Boston, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in digital healthcare enablement, will report its fourth quarter 2023 operating results on Wednesday, Feb. 14.

Amwell to Report Fourth Quarter and Full Year 2023 Operating Results on Feb. 14

Boston, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in digital healthcare enablement, today announced that SilverCloud® by Amwell earned three international healthcare honors. SilverCloud is a global digital mental health platform that provides 24/7 access to content and training for patients with mild to moderate symptoms of depression, anxiety and stress.

SilverCloud by Amwell Earns Three International Awards

Purple Innovation

CarParts.com, Inc.

Tax-loss selling occurs as investors dump their underperforming stocks to take the capital loss and wait 30 days to buy them back to avoid the wash rule. This causes underperforming stocks to fall in December and bounce back in January and February as investors buy back into the same shares.

3 more tax-loss selling buy opportunities

CVS Health

Doximity

Hims & Hers Health

Teladoc

The telehealth sector is undergoing a significant transformation, reshaping the traditional contours of medical service delivery. This innovation-driven domain is drawing attention from investors, as top telehealth stocks show potential in a rapidly expanding market.

5 Telehealth Stocks That Have Nothing But Upside

Although the revenue and EPS for American Well Corporation (AMWL) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

American Well Corporation (AMWL) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

American Well Corporation recently reported its Q3 2023 financial results, with a continued poor showing. The firm provides a telemedicine platform to healthcare system participants. Revenue continues to drop and operating losses remain extremely high, so my outlook on American Well Corporation is Bearish [Sell].

Amwell Looks To 2024 For Stabilization But Operating Losses Remain High

D-Wave Quantum Inc

Sirius XM Holdings Inc

Virgin Galactic

Uniti Group

The world of penny stocks is a bit like a treasure hunt—exciting, unpredictable, and full of potential finds. Let's talk about what's really getting traders' attention in these markets: it's all about volume.

5 Most Active Penny Stocks Today, Time To Buy?

American Well Corporation (NYSE:AMWL ) Q3 2023 Earnings Conference Call November 1, 2023 5:00 PM ET Company Participants Sue Dooley - Head-Investor Relations Ido Schoenberg - Chairman & Chief Executive Officer Bob Shepardson - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Stan Bernstein - Wells Fargo Securities Jailendra Singh - Truist Securities Jack Wallace - Guggenheim Securities Matt Shea - Needham & Company Charles Rhyee - TD Cowen Glen Santangelo - Jefferies David Larsen - BTIG Jessica Tassan - Piper Sandler Operator Good morning, good afternoon, and good evening. My name is Aaron and I'll be your conference operator for today.

American Well Corporation (AMWL) Q3 2023 Earnings Call Transcript

Telehealth firm Amwell announced strong third-quarter results for the year 2023 during an earnings call on Wednesday (Nov. 1). One of the key highlights of the quarter was Amwell securing a contract with the Defense Health Agency (DHA).

Amwell Reports Strong Third-Quarter Results, Deal With Defense Health Agency

BOSTON--(BUSINESS WIRE)--Amwell, a leader in hybrid care enablement, today announced financial results for the third quarter ended Sept. 30, 2023.

Amwell Announces Results for Third Quarter 2023

Amwell's Converge hybrid care platform was chosen to support the U.S. Military Health System. The project is in collaboration with Leidos, so there is no word yet as to Amwell's cut of the revenue.

News for American Well Corporation Stock (AMWL)